SCHEMBL9517366

SCHEMBL9517366

C(=C/Sc1ccccc1)\Sc1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.54
MAPT P10636 4/20 0.54
LMNA P02545 4/20 0.54
NPSR1 Q6W5P4 3/20 0.54
HPGD P15428 3/20 0.54
PLIN1 O60240 1/20 0.54
HTT P42858 1/20 0.54
PLIN5 Q00G26 1/20 0.54
ABHD5 Q8WTS1 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.50
MGLL Q99685 1/20 0.50
HSD17B10 Q99714 1/20 0.50
MAPK1 P28482 1/20 0.43
MEN1 O00255 1/20 0.41
NFKB1 P19838 1/20 0.41
NFKB2 Q00653 1/20 0.41
KMT2A Q03164 1/20 0.41
RELA Q04206 1/20 0.41
FFAR1 O14842 1/20 0.35
MAOB P27338 4/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9517373 1.00 ALDH1A1 (0.54) ALDH1A1MAPTLMNANPSR1HPGD
SCHEMBL9517370 1.00 ALDH1A1 (0.54) ALDH1A1MAPTLMNANPSR1HPGD
SCHEMBL18324553 0.83 ALDH1A1 (0.47) ALDH1A1MAPTLMNANPSR1HPGD
SCHEMBL9282890 0.83 ALDH1A1 (0.47) ALDH1A1MAPTLMNANPSR1HPGD
SCHEMBL775384 0.83 ALDH1A1 (0.47) ALDH1A1MAPTLMNANPSR1HPGD
SCHEMBL11033350 0.83 ALDH1A1 (0.47) ALDH1A1MAPTLMNANPSR1HPGD
SCHEMBL11033348 0.83 ALDH1A1 (0.47) ALDH1A1MAPTLMNANPSR1HPGD
SCHEMBL775383 0.83 ALDH1A1 (0.47) ALDH1A1MAPTLMNANPSR1HPGD
SCHEMBL7661995 0.83 ALDH1A1 (0.47) ALDH1A1MAPTLMNANPSR1HPGD
SCHEMBL9282887 0.83 ALDH1A1 (0.47) ALDH1A1MAPTLMNANPSR1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3411361-B1 NRF2 ACTIVATING COMPOUNDS AND USES THEREOF RIGEL PHARMACEUTICALS INC (US) 2020-11-25 EP disclosed
WO-2017136589-A1 NRF2 ACTIVATING COMPOUNDS AND USES THEREOF RIGEL PHARMACEUTICALS, INC. (US) 2017-08-10 WO disclosed
EP-0345847-B1 PROCESS FOR THE PREPARATION OF POLYMERS SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1993-08-04 EP disclosed
EP-0345847-A1 Process for the preparation of polymers SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1989-12-13 EP disclosed